Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1Phase 2 Interventional Results available

Celecoxib and Radiation Therapy in Treating Patients With Locally Advanced Non-Small Cell Lung Cancer

ClinicalTrials.gov ID: NCT00046839

Public ClinicalTrials.gov record NCT00046839. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 3:13 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase I/II Trial of a COX-2 Inhibitor, Celebrex (Celecoxib), [National Screening Committee# 719627] With Limited Field Radiation for Intermediate Prognosis Patients With Locally Advanced Non-Small Cell Lung Cancer, With Analysis of Prognostic Factors

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Celecoxib may stop the growth of tumor cells by stopping blood flow to the tumor and may make the tumor cells more sensitive to radiation therapy. PURPOSE: Phase I/II trial to study the effectiveness of combining celecoxib with radiation therapy in treating patients who have locally advanced non-small cell lung cancer.

Study identification

NCT ID
NCT00046839
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1, Phase 2
Enrollment
21 participants

Conditions and interventions

Conditions

Interventions

Drug · Radiation

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 2002 (Type not available)
Primary completion
Sep 2011 (Actual)
Completion
Not listed
Last update posted
Nov 17, 2015

Started 2002

United States locations

U.S. sites
44
U.S. states
20
U.S. cities
40
Facility City State ZIP Site status
Memorial Hospital Cancer Center Colorado Springs Colorado 80909 —
University of Florida Shands Cancer Center Gainesville Florida 32610 —
Baptist Cancer Institute - Jacksonville Jacksonville Florida 32207 —
University of Miami Sylvester Comprehensive Cancer Center Miami Florida 33136 —
Regional Radiation Oncology Center at Rome Rome Georgia 30165 —
Ingalls Cancer Care Center at Ingalls Memorial Hospital Harvey Illinois 60426 —
Indiana University Cancer Center Indianapolis Indiana 46202 —
Wendt Regional Cancer Center at Finley Hospital Dubuque Iowa 52001 —
Markey Cancer Center at University of Kentucky Chandler Medical Center Lexington Kentucky 40536 —
West Michigan Cancer Center Kalamazoo Michigan 49007 —
Virginia Piper Cancer Institute at Abbott-Northwestern Hospital Minneapolis Minnesota 55403 —
CCOP - Metro-Minnesota Saint Louis Park Minnesota 55416 —
Park Nicollet Clinic Saint Louis Park Minnesota 55416 —
CCOP - Kansas City Kansas City Missouri 64131 —
St. John's Regional Health Center Springfield Missouri 65804 —
Monmouth Medical Center Long Branch New Jersey 07740 —
Fox Chase Virtua Health Cancer Program - Marlton Mount Holly New Jersey 08060 —
Albuquerque Regional Medical Center at Lovelace Sandia Health System Albuquerque New Mexico 87102 —
University of New Mexico Cancer Research and Treatment Center Albuquerque New Mexico 87106 —
Trinity Cancer Care Center Minot North Dakota 58701 —
Akron City Hospital at Summa Health System Akron Ohio 44304 —
Radiation Oncology Center Alliance Ohio 44601 —
Cancer Research UK Medical Oncology Unit at Churchill Hospital & Weatherall Institute of Molecular Medicine - Oxford Salem Ohio 44460 —
Cancer Treatment Center Wooster Ohio 44691 —
Natalie Warren Bryant Cancer Center at St. Francis Hospital Tulsa Oklahoma 74136 —
Bryn Mawr Hospital Bryn Mawr Pennsylvania 19010 —
Cancer Center at Paoli Memorial Hospital Paoli Pennsylvania 19301 —
Fox Chase Cancer Center Philadelphia Pennsylvania 19111-2497 —
Mercy Hospital Cancer Center - Scranton Scranton Pennsylvania 18501 —
CCOP - MainLine Health Wynnewood Pennsylvania 19096 —
Lankenau Cancer Center at Lankenau Hospital Wynnewood Pennsylvania 19096 —
CCOP - Greenville Greenville South Carolina 29615 —
CCOP - Upstate Carolina Spartanburg South Carolina 29304 —
Utah Valley Regional Medical Center - Provo Provo Utah 84603 —
LDS Hospital Salt Lake City Utah 84143 —
Dixie Regional Medical Center St. George Utah 84770 —
St. Joseph Hospital Community Cancer Center Bellingham Washington 98225 —
North Star Lodge Cancer Center Yakima Washington 98902 —
Gundersen Lutheran Cancer Center at Gundersen Lutheran Medical Center La Crosse Wisconsin 54601 —
Community Memorial Hospital Menomonee Falls Wisconsin 53051 —
Medical College of Wisconsin Cancer Center Milwaukee Wisconsin 53226 —
Veterans Affairs Medical Center - Milwaukee (Zablocki) Milwaukee Wisconsin 53295 —
All Saints Cancer Center at All Saints Healthcare Racine Wisconsin 53405 —
University of Wisconsin Cancer Center at Aspirus Wausau Hospital Wausau Wisconsin 54401 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00046839, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 17, 2015 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00046839 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →